Genetic testing panels, more often than not, tend to focus these days on cancer. San Francisco’s Invitae is expanding its genetic testing panels past oncology into neurology, pediatrics and rare ...
SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that the company now offers a new Breast Cancer STAT Panel of high-quality genetic ...
SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced the expansion of its Breast Cancer STAT Panel with the addition of two important breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results